Corbus Pharmaceuticals: 3Q Earnings Snapshot

November 8, 2018

NORWOOD, Mass. (AP) _ Corbus Pharmaceuticals Holdings Inc. (CRBP) on Thursday reported a loss of $14.6 million in its third quarter.

The Norwood, Massachusetts-based company said it had a loss of 26 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.

The drug developer posted revenue of $1.1 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $1.7 million.

Corbus Pharmaceuticals shares have increased roughly 4 percent since the beginning of the year. The stock has climbed slightly more than 7 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRBP at https://www.zacks.com/ap/CRBP

Update hourly